¹Ð¸²ºÏ CI (±¸, ¸í¹®ÀÇÇм­Àû)
 
 
ÀÇÇм­Àû ȸ¿ø ·Î±×ÀÎ
¾ÆÀ̵ð ÀúÀå
ÀÇÇм­Àû °Ë»ö
 
ÀÇÇм­Àû Ä«Å×°í¸® ã±â
ÀÇÇм­Àû ºü¸¥ ¸Þ´º : ´õ¿í ºü¸£°í Æí¸®ÇÑ ¼­ºñ½º
¸Þ´º¾ó
USMLE
µµ¼­¹®ÀÇ°Ô½ÃÆÇ
¿Ü±¹µµ¼­ ¼öÀÔ½Åû
¿Ü±¹ ÀÇÇм­Àû ÃâÆǻ纰 / ÀÇÇм­Àû °úº°µµ¼­¸ñ·Ï
¾Æ¸¶Á¸ ÀÇÇм­Àû ¹Ù·Î°¡±â
01. ÀÇÇм­Àû¿¡ À¯¿ëÇÑ »çÀÌÆ®
02. ÀÇÇм­Àû ´º½º¸µÅ©
03. ȯÀ²Á¤º¸
Ä«µå»ç¿ë³»¿ª È®ÀÎ : Ä«µå¹øÈ£¿Í »ç¿ë±â°£À» ÀÔ·ÂÇÏ½Ã¸é °Å·¡³»¿ªÀ» Á¶È¸ÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
ÀÇÇм­Àû ´Üü±¸¸Å¾È³» : ÀÇÇм­Àû ´Üü±¸¸Å ¹× ÀÇÇм­Àû ´ë·®±¸¸Å¸¦ ¹®ÀÇÇϽøé Ä£ÀýÇÏ°Ô ÇØ°áÇص帳´Ï´Ù.
ÀÇÇм­Àû ±¸ÀÔ ¹«ÅëÀå ÀԱݾȳ» : ¿ì¸®ÀºÇà > 203-05-024131 / ³óÇù > 928-12-030605 | ¿¹±ÝÁÖ : À±ÁøÈñ
±¹¿Ü ÀÇÇм­Àû °Ë»ö
¾Æ¸¶Á¸ ÀÇÇм­Àû °Ë»ö
Barns&Noble ÀÇÇм­Àû °Ë»ö
Home °úº°µµ¼­¸ñ·ÏÀÇÇаúºÐ·ù±âÃÊÀÇÇнŰæ°úÇÐ
 
 
The Adenosinergic System: A Non-Dopaminergic Target in Parkinson's Disease
 

zoom
 
ÃâÆÇ»ç Springer
ÀúÀÚ Micaela Morelli, Nicola Simola, Jadwiga Wardas
Ãâ°£ÀÏ 2015/10
ÆäÀÌÁö ¼ö 396
Illustrations  
ISBN 9783319202723 (3319202723)
ÆǺ» 2015 ÆÇ
Ä¿¹ö Hardcover
ÁÖ¹®¼ö·®
List Price ¢æ 139.99
Á¤°¡ £Ü 210,000
ȸ¿ø°¡ £Ü 189,000
¡ØÇØ¿ÜÁÖ¹® µµ¼­ ¾È³» :

- ÇØ¿Ü ¹× ±¹³» ÀÔ°í »çÇ׿¡ µû¶ó 2~8ÁÖ ÀÌ»ó ¼Ò¿äµÉ ¼ö ÀÖÀ¸¸ç. Ãë¼Ò ¹× ¹ÝÇ°ÀÌ ºÒ°¡´ÉÇÕ´Ï´Ù.
- ÇØ¿ÜÁÖ¹®µµ¼­´Â ÇØ¿Ü ÃâÆÇ»ç »çÁ¤¿¡ ÀÇÇØ Ç°Àý/Áö¿¬µÉ¼ö ÀÖ½À´Ï´Ù.
¡Ø±³È¯ ¹× ¹ÝÇ°¾È³» :

- ±³È¯À̳ª ¹ÝÇ°½Ã »óÇ° ¼ö·ÉÈÄ 3ÀÏÀ̳» ±³È¯À̳ª ¹ÝÇ° Àǻ縦 ¾Ë·ÁÁֽðí ÀÏÁÖÀÏÀ̳»¿¡ ÀúÈñÂÊÀ¸·Î »óÇ°ÀÌ ÀÔ°íµÇ¾î¾ßÇÕ´Ï´Ù.
  ½ÃÀÏÀÌ °æ°úµÇ¸é ¹ÝÇ°ÀÌ ºÒ°¡ÇÕ´Ï´Ù.
- º¯½É¿¡ ÀÇÇÑ ±³È¯À̳ª ¹ÝÇ°½Ã, ¹è¼Ûºñ´Â °í°´´Ô²²¼­ ºÎ´ãÇϽøç, ¿À¹è¼ÛÀ̳ª »óÇ° ºÒ·®½Ã¿¡´Â ¹«·á ±³È¯ÀÌ °¡´ÉÇÕ´Ï´Ù.
- ¹ÝÇ°½Ã¿¡´Â ¹ÝÇ°»óÇ° °Ë¼öÈÄ Ä«µå Ãë¼Ò¸¦ Çص帮°Å³ª ÅëÀå,Àû¸³±ÝµîÀ¸·Î ȯºÒ Á¶Ä¡ ÇØ µå¸³´Ï´Ù.
¡Ø¹è¼Û¾È³» :

- Á¦ÁÖµµ¹× µµ¼­»ê°£Áö¿ªÀº Åùèºñ°¡ Ãß°¡µÉ¼ö ÀÖ½À´Ï´Ù.
µµ¼­ ¼Ò°³ | ¸ñÂ÷ | ¼­Æò¾²±â
 
 
 
Adenosine A2A receptor antagonists have shown great promise in the treatment of Parkinson's Disease and alleviation of symptoms. This book addresses various aspects of this class of drugs from their chemical development to their clinical use. Among the many insightful chapters contained in this book, there are three unique reviews that have not previously been published in any format: (1) a history of istradefylline, the first A2A antagonist approved for treatment of Parkinson's Disease, (2) an overview of neuroimaging studies in human death and disease and (3) a study of urate as a possible biomarker and neuroprotectant.
 
 
 
 
 
 
¼­Æò | µî·ÏÀÏ | ÀÛ¼ºÀÚ
µî·ÏµÈ ¼­ÆòÀÌ ¾ø½À´Ï´Ù.
 
 
 
ÀÛ¼ºÀÚ ¾ÏÈ£
 
µµ¼­ ¼Ò°³ | ¸ñÂ÷ | ¼­Æò¾²±â
 
Why? ¹Ð¸²ºÏ ¼­ÀûÀº ¿Ö Àú·ÅÇÑ°¡¿ä?
ÀÇÇм­Àû Ãâ°£¿¹Á¤µµ¼­ Ãâ°£¿¹Á¤µµ¼­ ´õº¸±â
ÀÇÇм­Àû Ãâ°£¿¹Á¤µµ¼­
Marino's The ICU Book, 5th Edition
£Ü 160,000
ÀÇÇм­Àû ÆÄ°ÝÇÒÀεµ¼­ 30~70% SALE
ÇÑ´«¿¡ ¾Ë ¼ö ÀÖ´Â Àç»ýÅëÁõÄ¡·á - °³¿øÀǸ¦ À§ÇÑ (spiral bound) ±¸¸ÅÇϱâ
¼Ò±Ô¸ð °Ç¹° Áþ±â ½ÇÀü°ø½Ä: °ÇÃàÁÖ°¡ ¾Ë¾Æ¾ß ÇÒ ºÎ½Ç°ø»ç ¹æÁöÃ¥
³»°¡ ¸¸³­ ±æ°í¾çÀ̵é 1